Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Risk Stratification of Upper Tract Urothelial Carcinoma for Kidney-Sparing Surgery Publisher



Parizi MK1, 2, 3, 4 ; Fajkovic H1, 3, 4 ; Shariat SF1, 3, 4, 5, 6, 7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Urology, Medical University of Vienna, Vienna, Australia
  2. 2. Department of Urology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Urology, Medical University of Vienna, Vienna, Australia
  4. 4. Department of Urology, Medical University of Vienna, Vienna, Australia
  5. 5. Department of Urology, Weill Cornell Medical College, New York, NY, United States
  6. 6. Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX, United States
  7. 7. Karl Landsteiner Institute of Urology and Andrology, Vienna, Australia

Source: Bladder Cancer: A Practical Guide Published:2021


Abstract

Several prognostic factors have been identified to risk stratify patients with upper tract urothelial carcinoma (UTUC). However, due to heterogeneity of these prognosticators and the presence of different therapeutic modalities for this rare and heterogeneous disease, decision-making and patient consultation remains challenging. In this chapter, we provided an overview of the prognostic factors that can help risk stratify patients for kidney-sparing versus radical surgery. Several studies confirmed the value of patient- and tumor-related factors for prognosticating oncological outcomes in UTUC patients. However, due to the retrospective nature of these studies, the true clinical impact needs to be assessed in well-designed prospective controlled studies to increase the accuracy and fortify evidence-driven clinical decision-making process. It is today clear that biomarkers are needed to capture the biologic and clinical potential of each individual tumor. © Springer Nature Switzerland AG 2021.